Journal Guide

Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For over 50 years Drugs has been the definitive journal of drugs and therapeutics, promoting optimum pharmacotherapy by publishing reviews and original clinical research authored by leading international clinicians and researchers to support clinical decision-making.   

Through a rigorous and comprehensive program of peer-reviewed evaluations, Drugs provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.

As a hybrid journal, Drugs does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require (more information).

Drugs offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content (more information).

For 30 years Drugs & Aging has been delivering essential information on the most important aspects of drug therapy to researchers and healthcare professionals involved in the care of older patients.

Through a program of reviews and original research articles, the journal addresses major issues relating to drug therapy in older adults, including the management of specific diseases or disorders, particularly those associated with aging, age-related physiological changes impacting drug therapy, and issues related to drug utilization and prescribing.

As a hybrid journal, Drugs & Aging does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require (more information).

Drugs & Aging offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content (more information).

Drugs & Therapy Perspectives provides concise, authoritative review articles to aid drug formulary and prescribing decisions. It is a digest of the latest drug knowledge covering the most important aspects of clinical therapeutics, including:Questions and answers on the clinical use of drugs.Comparisons of the features of various drugs, using differential feature tables.Current thinking on disease management.Step-by-step clinical decision-making, illustrated with patient care algorithms.First reports of serious adverse drug reactions.Clinically useful pharmacodynamics and pharmacokinetics.Developments in pharmacoeconomics and other research that have a bearing on clinical practice.All material is prepared by Adis editors and medical writers, unless otherwise noted. The preparation of material is not supported by any external funding. All review articles are subject to peer review by members of the journal's international editorial board and/or other experts.

Drugs - Real World Outcomes targets research involving the use of real-world data to evaluate health outcomes and inform healthcare decision-making, with a particular focus on healthcare-related 'big data'. Drugs - Real World Outcomes has a broad scope, encompassing studies investigating drug utilisation, patterns of prescribing, pharmacovigilance, treatment guideline adherence, benefit-risk assessments, comparative effectiveness and economic analyses.

Drugs and Alcohol Today journal is committed to bringing together scientific research as well as practitioner and policy reports on the social, economic, and political aspects of alcohol and other drugs.

Drugs in R&D is an international, peer reviewed, open access, online only journal, which provides timely information on emerging drug classes and new treatments for specific disorders in an ‘open access’ format for all to review. Original research and reviews from all phases of clinical development are included, with a strong link to clinical practice. Healthcare decision makers are thus provided with clinically applicable knowledge about the likely place in therapy of a drug.Journal issues comprise:·        Original research on new drugs, including clinical trials:·        New research on established drugs.·        R&D Insight reports:Short communications and letters to the editor are welcomed and will be considered for publication. Reviews may also be considered. All manuscripts are subject to peer review by international experts.

Drugs, Habits and Social Policy journal is committed to bringing together research on the cultural, social and material contexts of drug use, policy, and professional practices

Drugs: education, prevention & policy is a refereed journal which aims to provide a forum for communication and debate between policy makers, practitioners and researchers concerned with social and health policy responses to legal and illicit drug use and drug-related harm. The journal publishes multi-disciplinary research papers, commentaries and reviews on policy, prevention and harm reduction issues regarding the use and misuse of alcohol, tobacco and other drugs. It is journal policy to encourage submissions which reflect different cultural, historical and theoretical approaches to the development of policy and practice.The Editor welcomes contributions based on original research, policy discussion, evaluations of policy and practice, literature reviews, and papers which examine historical and cultural aspects of substance use and social responses to use and problematic use.Short contributions are also welcome for two new sections in the journal:Policy News will aim to provide information and discussion on current policy developments and issues of national or international importance in prevention or harm reductionConference Reports is intended to provide brief accounts, from the contributor’s point of view, of the themes and outcomes from national or international conferences.Read More: http://informahealthcare.com/page/dep/Description.

Drus?tvena istraz?ivanja is a journal for general social issues, embracing complete thematic and disciplinary openness. It publishes works in different social disciplines (sociology, psychology, political science, psychiatry, history, law, economics, demography, linguistics etc.), but also publishes work that transcends the frontiers of individual disciplines. Papers are subject to anonymous review procedures. .

The "Drvna industrija" ("Wood Industry") journal publishes original scientific and review papers, short notes, professional papers, conference papers, reports, professional information, bibliographical and survey articles and general notes relating to the forestry exploitation, biology, chemistry, physics and technology of wood, pulp and paper and wood components, including production, management and marketing aspects in the woodworking industry.

Dryad is an open source, community driven project that takes a unique approach to data publication and digital preservation. Dryad focuses on search, presentation, and discovery and delegates the responsibility for the data preservation function to the underlying repository with which it is integrated.

For information about submission to Dryad, see our guidance here.

Dr. Arun S. Mujumdar received the Doctor Honoris Causa Award from Lodz Technical University in June 2008! Find out more This multidisciplinary, English-language journal explores, in depth, the science, technology, and engineering of drying, dewatering, and related topics. Articles in Drying Technology cover transport phenomena in porous media, heat and mass transfer in single or multiphase systems, evaporation, solid/liquid separation, powder technology, fluidization, agglomeration, gas-solid systems, humidity and solid moisture content measurements/control, and more. Publication Office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.